Mesoblast (MESO) Gains from Investment Securities (2014 - 2025)

Mesoblast (MESO) has reported Gains from Investment Securities for 12 consecutive years, with $5.0 million the latest figure, recorded in Q4 2025.

• Quarterly Gains from Investment Securities rose 736.97% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 736.97% YoY) and the FY2022 annual result came in at $5.9 million, down 68.45% from the prior year.
• Gains from Investment Securities grew to $5.0 million in Q4 2025 per MESO's latest filing, from -$779000.0 in the prior quarter.
• Over the last five years, Gains from Investment Securities for MESO reached as high as $6.5 million in Q2 2022 and fell as low as -$5.9 million in Q4 2022.
• A 5-year average of $690000.0 and a median of $628000.0 in 2021 frame the typical range for Gains from Investment Securities.
• The largest YoY upside for Gains from Investment Securities was 1495.71% in 2022 against a maximum downside of 1579.77% in 2022.
• Year by year, Gains from Investment Securities stood at -$351000.0 in 2021, then tumbled by 1579.77% to -$5.9 million in 2022, then jumped by 137.4% to $2.2 million in 2023, then tumbled by 135.33% to -$779000.0 in 2024, then jumped by 736.97% to $5.0 million in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $5.0 million, -$779000.0, and $2.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.